United Therapeutics Corp. can add another regulatory thumbs-up to its growing collection. The Silver Spring biotech has earned Food and Drug Administration approval for another use of Orenitram, a pulmonary arterial hypertension drugs first approved in 2013 to improve patients’ ability to exercise. The agency’s new stamp means the drug’s label can now reflect that it delays the disease’s progression when used with another type of PAH therapy, United Therapeutics (NASDAQ: UTHR) said Monday. In…
from https://www.bizjournals.com/baltimore/news/2019/10/22/united-therapeutics-scores-another-fda-approval.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/188518216257
No comments:
Post a Comment